PDT Partners LLC boosted its position in CME Group Inc. (NASDAQ:CME – Free Report) by 29.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 77,805 shares of the financial services provider’s stock after purchasing an additional 17,798 shares during the quarter. CME Group comprises about 1.5% of PDT Partners LLC’s portfolio, making the stock its biggest holding. PDT Partners LLC’s holdings in CME Group were worth $17,168,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CME. Truvestments Capital LLC acquired a new stake in shares of CME Group in the third quarter valued at approximately $26,000. Y.D. More Investments Ltd acquired a new position in CME Group in the 2nd quarter valued at $36,000. McClarren Financial Advisors Inc. raised its holdings in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares in the last quarter. Asset Dedication LLC lifted its position in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. grew its holdings in shares of CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after purchasing an additional 74 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on CME. Morgan Stanley boosted their price target on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Citigroup boosted their target price on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research report on Tuesday, October 8th. Finally, Barclays raised their target price on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average target price of $224.47.
Insider Buying and Selling
In related news, Director Martin J. Gepsman sold 400 shares of CME Group stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at $5,587,935.64. The trade was a 1.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 8,028 shares of company stock valued at $1,811,681 over the last 90 days. 0.30% of the stock is owned by insiders.
CME Group Price Performance
Shares of CME opened at $238.00 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a market cap of $85.77 billion, a PE ratio of 25.03, a PEG ratio of 5.47 and a beta of 0.55. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $238.97. The business has a 50-day simple moving average of $225.55 and a two-hundred day simple moving average of $211.93.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the firm posted $2.25 earnings per share. The firm’s revenue was up 18.4% compared to the same quarter last year. Analysts anticipate that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 1.93%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- ESG Stocks, What Investors Should Know
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 3 Penny Stocks Ready to Break Out in 2025
- With Risk Tolerance, One Size Does Not Fit All
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.